The impact of anemia on energy and physical functioning in individuals with AIDS

被引:30
作者
Semba, RD
Martin, BK
Kempen, JH
Thorne, JE
Wu, AW
机构
[1] Johns Hopkins Univ, Sch Med, Div Ocular Immunol, Dept Ophthalmol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA
关键词
D O I
10.1001/archinte.165.19.2229
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: To our knowledge, the relationship between changes in hemoglobin level and energy and physical functioning in the anemic and "normal" ranges of hemoglobin among individuals with AIDS has not been well characterized. Methods: In a multicenter, prospective, cohort study involving 19 clinics in the United States, 1406 individuals, 13 years and older, with AIDS were administered the Medical Outcomes Study HIV [human immunodeficiency virus] Health Survey (MOS-HIV) at baseline and at 3- to 6-month follow-up visits. Energy and physical functioning scores were the main outcomes. Results: At baseline, a higher hemoglobin level was associated with a higher energy score and a higher physical functioning score (P <.001 for both), after adjusting for CD4 lymphocyte count, sex, age, education, and HIV risk factor. In longitudinal analyses, increases in hemoglobin were associated with increases in energy and physical functioning scores (P <.001 for both), after adjusting for CD4 lymphocyte count, sex, age, education, and HIV risk factor. Changes in the energy scales were, on average, 1.5 and 2.3 scale points per 1-g/dL change in hemoglobin level in the normal and anemic ranges, respectively. For the physical functioning scale, average changes were 2.7 and 2.6 scale points per 1-g/dL change in hemoglobin level in the normal and anemic ranges, respectively. Conclusions: Higher levels of hemoglobin are associated with better quality of life among individuals with AIDS. Changes in hemoglobin level within the conventional normal range of hemoglobin are also significantly associated with changes in quality of life.
引用
收藏
页码:2229 / 2236
页数:8
相关论文
共 27 条
[11]   Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe [J].
Mocroft, A ;
Kirk, O ;
Barton, SE ;
Dietrich, M ;
Proenca, R ;
Colebunders, R ;
Pradier, C ;
Monforte, AD ;
Ledergerber, B ;
Lundgren, JD .
AIDS, 1999, 13 (08) :943-950
[12]  
Moore RD, 2002, J ACQ IMMUN DEF SYND, V29, P54, DOI 10.1097/00042560-200201010-00007
[13]  
REVICKI DA, 1994, J ACQ IMMUN DEF SYND, V7, P474
[14]   Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS - A double-blind, randomized trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine [J].
Safrin, S ;
Finkelstein, DM ;
Feinberg, JD ;
Frame, P ;
Simpson, G ;
Wu, A ;
Cheung, T ;
Soeiro, R ;
Hojczyk, P ;
Black, JR .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (09) :792-+
[15]   Risk factors and cumulative incidence of anaemia among HIV-infected injection drug users [J].
Semba, RD ;
Shah, N ;
Vlahov, D .
INTERNATIONAL JOURNAL OF STD & AIDS, 2002, 13 (02) :119-123
[16]   Pathogenesis of anemia during human immunodeficiency virus infection [J].
Semba, RD ;
Gray, GE .
JOURNAL OF INVESTIGATIVE MEDICINE, 2001, 49 (03) :225-239
[17]   Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women [J].
Semba, RD ;
Shah, N ;
Klein, RS ;
Mayer, KH ;
Schuman, P ;
Vlahov, D .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (02) :260-266
[18]   Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: Results from the multistate adult and adolescent spectrum of HIV disease surveillance project [J].
Sullivan, PS ;
Hanson, DL ;
Chu, SY ;
Jones, JL ;
Ward, JW .
BLOOD, 1998, 91 (01) :301-308
[19]   Consensus statement: Anemia in HIV infection - Current trends, treatment options, and practice strategies [J].
Volberding, P .
CLINICAL THERAPEUTICS, 2000, 22 (09) :1004-1020
[20]   Anemia in HIV infection: Clinical impact and evidence-based management strategies [J].
Volberding, PA ;
Levine, AM ;
Dieterich, D ;
Mildvan, D ;
Mitsuyasu, R ;
Saag, M .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (10) :1459-1468